Matches in Wikidata for { <http://www.wikidata.org/entity/Q98165264> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q98165264 description "article scientifique publié en 2020" @default.
- Q98165264 description "artículu científicu espublizáu en xunetu de 2020" @default.
- Q98165264 description "scientific article published on 30 July 2020" @default.
- Q98165264 description "wetenschappelijk artikel" @default.
- Q98165264 description "наукова стаття, опублікована 30 липня 2020" @default.
- Q98165264 name "Simplification to dual therapy containing lamivudine and raltegravir or dolutegravir in HIV-infected patients on virologically suppressive antiretroviral therapy" @default.
- Q98165264 name "Simplification to dual therapy containing lamivudine and raltegravir or dolutegravir in HIV-infected patients on virologically suppressive antiretroviral therapy" @default.
- Q98165264 type Item @default.
- Q98165264 label "Simplification to dual therapy containing lamivudine and raltegravir or dolutegravir in HIV-infected patients on virologically suppressive antiretroviral therapy" @default.
- Q98165264 label "Simplification to dual therapy containing lamivudine and raltegravir or dolutegravir in HIV-infected patients on virologically suppressive antiretroviral therapy" @default.
- Q98165264 prefLabel "Simplification to dual therapy containing lamivudine and raltegravir or dolutegravir in HIV-infected patients on virologically suppressive antiretroviral therapy" @default.
- Q98165264 prefLabel "Simplification to dual therapy containing lamivudine and raltegravir or dolutegravir in HIV-infected patients on virologically suppressive antiretroviral therapy" @default.
- Q98165264 P1433 Q98165264-4FEB8ADD-5BBF-4038-A7AF-DA1F4D0B8829 @default.
- Q98165264 P1476 Q98165264-8E9A5D87-D2EA-4632-AFD7-8A0534622F42 @default.
- Q98165264 P2093 Q98165264-07E76664-0A22-4132-8872-6D5E820BC44E @default.
- Q98165264 P2093 Q98165264-3E861223-7786-4D04-A395-E5649EB09EAE @default.
- Q98165264 P2093 Q98165264-49FDD156-AF7C-4D39-8874-A6159D4B141C @default.
- Q98165264 P2093 Q98165264-B15FBB7C-08E5-4DBD-9C83-1DCFC3C82658 @default.
- Q98165264 P2093 Q98165264-D678B50B-5A10-474B-91F2-188D00BEB731 @default.
- Q98165264 P2093 Q98165264-F291EA8B-4C87-4655-974A-16530BD3538F @default.
- Q98165264 P2093 Q98165264-F62C49B3-C31E-4700-8D1E-343C6D357FE4 @default.
- Q98165264 P31 Q98165264-75AA7EDE-210F-4612-8641-1D4D1E4943A6 @default.
- Q98165264 P356 Q98165264-6D4AD17E-E978-4DA4-8DDC-9A57DD05EF87 @default.
- Q98165264 P50 Q98165264-18083CCF-F018-4A40-B5FD-EA1C20AFF3AD @default.
- Q98165264 P577 Q98165264-AB17D56D-4955-4323-BAEA-F4482464628A @default.
- Q98165264 P698 Q98165264-28211EBD-EBE6-4288-8CF5-6E7BAE9CFFF2 @default.
- Q98165264 P921 Q98165264-7A40BB64-10C3-4AAB-B6A3-DE1742657E2C @default.
- Q98165264 P921 Q98165264-A146E9B5-8F95-41CE-AE7B-293965FBFC68 @default.
- Q98165264 P921 Q98165264-A7B60E3B-0928-4A36-B4EB-E2B6C741815B @default.
- Q98165264 P356 DKAA319 @default.
- Q98165264 P698 32728708 @default.
- Q98165264 P1433 Q6294770 @default.
- Q98165264 P1476 "Simplification to dual therapy containing lamivudine and raltegravir or dolutegravir in HIV-infected patients on virologically suppressive antiretroviral therapy" @default.
- Q98165264 P2093 "Bianca Granozzi" @default.
- Q98165264 P2093 "Diletta Testi" @default.
- Q98165264 P2093 "Isabella Bon" @default.
- Q98165264 P2093 "Leonardo Calza" @default.
- Q98165264 P2093 "Marco Borderi" @default.
- Q98165264 P2093 "Maria Carla Re" @default.
- Q98165264 P2093 "Vincenzo Colangeli" @default.
- Q98165264 P31 Q13442814 @default.
- Q98165264 P356 "10.1093/JAC/DKAA319" @default.
- Q98165264 P50 Q113862183 @default.
- Q98165264 P577 "2020-07-30T00:00:00Z" @default.
- Q98165264 P698 "32728708" @default.
- Q98165264 P921 Q421552 @default.
- Q98165264 P921 Q422631 @default.
- Q98165264 P921 Q937224 @default.